Curriculum Vitae – Saba Kiremitci M.D.

CURRICULUM VITAE

Saba (Haciahmetoglu) Kiremitci, M.D.

PERSONAL DATA:

Name/Surname Saba (Haciahmetoglu) Kiremitci

Sex Female

Place of Birth Trabzon, Turkey

Nationality Turkish

Foreign Languages Spoken English

Current Appointment Assistant Professor of Pathology

Faculty of Medicine, University of Ankara,

Ankara, Turkey

Office Address Ankara University Faculty of Medicine

Department of Pathology, Morfoloji Campus

Sihhiye, Ankara, Turkey

Tel: (+)90-312-3103010 / ext:8103

Fax: (+) 90-312-3106370

E-mail: kiremitcisaba@gmail.com

Curriculum Vitae – Saba Kiremitci M.D.

MEDICAL LICENSURE:

Medical Doctor

(1995-2001) Faculty of Medicine, The University of Gazi, Ankara, Turkey

(6 year program)

Residency in Pathology

(2002-2006) Faculty of Medicine, The University of Ankara,

Department of Pathology, Ankara, Turkey

Thesis: Renal cell carcinoma: characterization of phenotype and

proliferative activity. An immunohistochemical study

Degree: Specialist in Pathology (March 29, 2006)

Specialist

(2006 – 2007) Department of Pathology,

ZTB Obstetric and Gynecology Teaching and Research State

Medical Hospital, Ankara, Turkey

(2007 – 2009) Department of Pathology,

Urological and Gastrointestinal Surgical Pathology,

Yuksek Ihtisas Teaching and Research State Medical Hospital

Ankara, Turkey

(2009 - 2013) The University of Ankara, Faculty of Medicine

Department of Pathology Ankara, Turkey

Assistant Professor

(2013 – Present)

Department of Pathology, Faculty of Medicine,

The University of Ankara, Ankara, Turkey

PROFESSIONAL MEMBERSHIPS:

1. European Society of Pathology (ESP)

2. Ankara Pathology Society

3. Turkish Society of Urooncology

4. Turkish Working Group Society of Nephropathology

(position: working group secretary)

5. Turkish Working Group Society of Uropathology

Curriculum Vitae – Saba Kiremitci M.D.

AWARDS AND DISTINCTIONS:

1. The Best Junior Researcher / Murat B. Alkanat Award, given by Aegean Pathology Society

in XVIII. National Symphosium of Pathology, May 7-11, Izmir, Turkey

With the study: (oral presentation) Kiremitci S, Tulunay O, Baltacı S, Perçinel S.

The Role of CyclinD1, CyclinD3, CyclinE, p27, CD44, MUC1, CK7 and CK20 in

Characterization of Phenotype and Prognosis in Renal Cell Carcinoma.

2. Highest score in case studies exam at the end of the course; Basel Seminars in Pathology.

Renal Transplant Pathology Hands-on Course, 27-30 June, 2016, Basel, Switzerland

ORGANIZED SCIENTIFIC ACTIVITIES

1. EScoP Nephropathology course, European Society of Pathology – Ankara Patoloji Derneği, 26-28

November, 2015, Ankara, Turkey

INVITED SPEAKER in INTERNATIONAL SCIENTIFIC MEETINGS

1. Kiremitci S

Systemic kidney diseases; Lupus nephritis, Case demonstration and discussion

Precongress course “Histopathology”

51st Annual Scientific Meeting of the European Society of Paediatric Nephrology,

October 3, 2018

Antalya, Turkey

2. Kiremitci S

Kidney Transplantation Nephrology; Pathological Assessment of Allograft Biopsy

1st International Transplant Network Congress

October 17-21, 2018

Antalya, Turkey

3. Kiremitci S.

SS-08 Slide Seminar, Joint Slide Seminar Electron Microscopy / Nephropathology, Light and

electron microscopy in the diagnostic work-up of kidney biopsies CASE 004.

XXXI International Congress of the IAP and 28th Congress of the ESP

September 25-29, 2016

Cologne, Germany

Curriculum Vitae – Saba Kiremitci M.D.

ATTENDED INTERNATIONAL SCIENTIFIC ACTIVITIES

1. 30th European Congress of Pathology, 08 - 12 September, 2018, Bilbao, Spain

2. Precongress course “Histopathology”, 51st Annual Scientific Meeting of the European

Society of Paediatric Nephrology, 3 October,, 2018, Antalya, Turkey

3. 1st International Transplant Network Congress, 17-21 October, 2018, Antalya, Turkey

4. Basel Seminars in Pathology. Renal Transplant Pathology Hands-on Course, 27-30 June,

2016, Basel, Switzerland

5. XXXI International Congress of the IAP and 28th Congress of the ESP, 25-29

September, 2016, Cologne, Germany

6. RPS-Renal Pathology Society Symposium 2016, 25 September 2016, Cologne, Germany

7. EScoP Nephropathology Course, European Society of Pathology, 26-28 November, 2015, Ankara,

Turkey

8. International Course on Native and Transplant Renal Biopsy Interpretation, June 5-7,

2014, Ljubljana, Slovenia

9. Digital Pathology Congress, 4-5 December 2014, London, UK

10. “HER2 Testing in Gastric Cancer”, one day course, 2012, Ankara, Turkey

11. “Update in Gynaecopathology - EScoP, European Society of Pathology, 2012, Ankara,

Turkey

12. 99th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP),

2010, Washington DC, USA

13. 4th Arkadi M. Rywlin International Pathology Slide Seminar Symposium in Anatomic

Pathology, 2010, Istanbul, Turkey

14. 21st European Congress of Pathology, EScoP - Türk Patoloji Derneği, Eylül 2007,

Istanbul, Turkey

15. “Head and Neck Pathology” EScoP course, 2006, Ankara, Turkey

16. Gastrointestinal Pathology Workshop, EScoP course, 2006, Ankara, Turkey

17. “Pathology of pancreas and gastrointestinal endocrine tumors” EScoP course, 2005,

Ankara, Turkey

18. “Pulmonary Pathology” EScoP, 2004, Ankara, Turkey

Curriculum Vitae – Saba Kiremitci M.D.

PUBLISHED BOOK CHAPTERS

1. Carneiro F, Chaves P, Ensari A (Ed.) (2017), Pathology of the Gastrointestinal Tract.

1st ed., Springer in: Kiremitci S, Small intestine, Gangliocytic Paraganglioma,

Duodenal, pages: 257-260

PUBLISHED PAPERS

1. Bal NB, Han S, Usanmaz SE, Kiremitci S, Sadi G, Uludağ O, Demirel-Yilmaz E. Activation

of Liver X Receptors by GW3965 attenuated DOCA-salt hypertension-induced cardiac

functional and structural changes. J Cardiovasc Pharmacol. 2019 Jul 22.

doi: 10.1097/FJC.0000000000000693. [Epub ahead of print]

2. Kiremitci S, Dizbay Sak S. Comparative immunohistochemical characteristics of benign and

malignant major salivary gland tumors: A retrospective study. Tr-ENT 2019;29(1):9-20.

3. Hasanov R, Aydoğan Bİ, Kiremitçi S, Erden E, Güllü S. The Prognostic Roles of the Ki-67

Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in

Pituitary Adenomas. Endocr Pathol. 2019 Mar;30(1):49-55.

doi: 10.1007/s12022-018-9563-2.

4. Başaran Ö, Uncu N, Çakar N, Turanlı ET, Kiremitci S, Aydın F, Bayrakcı US. C3

glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review.

Rheumatol Int. 2018 Aug;38(8):1571-1576.

doi: 10.1007/s00296-018-4092-3.

5. Erdogmus S, Kiremitci S, Kendi Celebi Z, Akturk S, Duman N, Ates K, Erturk S,

Nergizoğlu G, Kutlay S, Sengul S, Ensari A, Keven K. Non-diabetic kidney disease in type 2

diabetic patients: prevalence, clinical predictors and outcomes. Kidney Blood Press Res

2017;42:886-93.

doi:10.1159/000484538

6. Kendi Celebi Z, Kiremitci S, Ozturk B, Akturk S, Erdogmus S, Duman N, Ates K, Erturk S,

Nergizoglu G, Kutlay S, Sengul S, Ensari A, Keven K. Kidney biopsy in AA amyloidosis:

impact of histopathology on prognosis. Amyloid. 2017 Jul 7:1-7.

doi: 10.1080/13506129.2017.1350158.

7. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Prognostic impact of epidermal growth

factor receptor on clear cell renal cell carcinoma: Does it change with different expression

patterns? Indian J Pathol Microbiol. 2016 Jan-Mar;59(1):35-40.

doi: 10.4103/0377-4929.178219.

8. Taktak A, Köksoy A, Başaran Ö, Kiremitci S, Acar B, Uncu N, Çakar N. An unexpected

diagnostic course of systemic lupus erythematosus. Turk J Pediatr. 2016;58(2):223-226.

Curriculum Vitae – Saba Kiremitci M.D.

9. Erdogmuş S, Akturk S, Kendi Celebi Z, Kiremitci S, Kaygusuz S, Altınbas NM, Ustuner E,

Keven K. Diffuse large B cell lymphoma presenting with bilateral renal masses and

hematuria: Case report. Turk J Hematol. 2016 Jun 5;33(2):159-62.

doi: 10.4274/tjh.2015.0238

10. Gur G, Cakar N, Kiremitci S, Taktak A, Basaran O, Uncu N. Pulmonary hemorrhage, a rare

complication in a girl with Henoch-Schönlein purpura. Arch Argent Pediatr. 2016 Oct

1;114(5):e366-9.

doi: 10.5546/aap.2016.eng.e366. Epub 2016 Oct 1.

11. Yılmaz S, Özçakar ZB, Taktak A, Kiremitci S, Ensari A, Dinçaslan H, Yalçınkaya F. Anti-

VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.

Pediatr Nephrol. 2016 Jun;31(6):1029-32.

doi: 10.1007/s00467-016-3355-z. Epub 2016 Feb 29.

12. Sönmez DY, Peker E, Kiremitci S, Erden A, Kuzu A. Accuracy of MR imaging in

preoperative staging of rectal cancer. Journal of Ankara University Faculty of Medicine

(Ankara Üniversitesi Tıp Fakültesi Mecmuası) 2016,69 (3):173-179

13. Çetintaş D, Aral A, İnan MH, Karabörk Kırmızı BA, Kiremitci S, Avcı A, Şırlak M, Akar

AR. Suprarenal kros klempe bağlı oluşan renal hasarın iskemik önkoşullanma ve karnitin ile

önlenmesi: Deneysel çalışma. (Prevention of renal injury due to suprarenal cross-clamping

with ischemic preconditioning and carnitine: an experimental study.) Turk Gogus Kalp

Damar 2016;24(3):522-31. doi: 10.5606/tgkdc.dergisi.2016.12251

14. Küçük G, Ateş U, Göllü G, Kiremitci S, Dindar H. Lipoblastoma in the inguinal region of an

infant: Review of the literature. Journal of Ankara University Faculty of Medicine, Ankara

Üniversitesi Tıp Fakültesi Mecmuası 2016, 69 (3): 253-255

15. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Gelsolin, NF-κB, and p53 expression in clear

cell renal cell carcinoma: Impact on outcome. Pathol Res Pract. 2015 Jul;211(7):505-12.

doi: 10.1016/j.prp.2015.03.002.

16. Neşe N, Kumbaraci BS, Baydar DE, Kiliçaslan I, Sari AA, Şen S, Gönül II, Kankaya

D, Özlük Y, Ermete M, Özağari A, Bal N, Kiremitci S, Yildiz K, Tuna B, Şen N,Yörükoğlu

K. Small Cell Carcinomas of the Bladder Highly Express Somatostatin Receptor Type 2A:

Impact on Prognosis and Treatment-A Multicenter Study of Urooncology Society, Turkey.

Appl Immunohistochem Mol Morphol. 2015 Jul 1.

17. Kiremitci S, Ensari A. Classifying lupus nephritis: an ongoing story.

ScientificWorldJournal. 2014;2014:580620.

doi: 10.1155/2014/580620

Curriculum Vitae – Saba Kiremitci M.D.

18. Kiremitci S, Ensari A. Son Gelişmeler Işığında Lupus Nefriti Patogenezi. Turk Neph Dial

Transpl 2014; 23 (3): 175-180.

doi:10.5262/tndt.2014.1003.01

19. Yılmaz S, Özçakar ZB, Bulum B, Kiremitci S, Ensari A, Ekim M, Keven K, Yalçınkaya F.

De novo amyloidosis in a renal transplant patient. Pediatr Transplant. 2014 Dec;18(8):E259-

61. doi: 10.1111/petr.12344.

20. Ersöz CC, Kankaya D, Kiremitçi S, Kaygusuz G. Fibroblastik/myofibroblastik benign ve

lokal agresif neoplaziler ve nörofibromalarda DOG1 ekspresyon profili (DOG1 expression

profile of benign and locally aggressive fibroblastic/myofibroblastic neoplasms and

neurofibromas.) Cumhuriyet Med J 2014; 36: 227-230. doi: 10.7197/1305-0028.5010

21. Unlu M, Kiremitci S, Ensari A, Ozluk Y, Kilicaslan I, Ozdemir BH, Ates D, Ertoy Baydar

D, Gonul II, Memis L, Sarsik B, Sen S, Akkaya B, Orhan D, Gonlusen G, Ellidokuz H, Ada

S, Cavdar C, Akagun T, Kamali S, Aksu K, Yazisiz V, Paydas S, Soylu A, Sarioglu S. Pauci-

immune necrotizing crescentic glomerulonephritis with crescentic and full moon

extracapillary proliferation: clinico-pathologic correlation and follow-up study. Pathol Res

Pract, Feb 15;209(2):75-82 (2013)

22. Ak Ergün F, Ağırbaş İ, Kuzu I. Activity-Based Costing for Pathology Examinations and

Comparison with the Current Pricing System in Turkey. (Patoloji Tetkiklerinde Faaliyet

Tabanlı Maliyet Hesaplaması ve Güncel Fiyatlandırma Sistemi İle Karşılaştırılması.) Turk

Patoloji Derg 2013, 29:1-14. doi: 10.5146/tjpath.2013.01141,

(araştırma makalesi /ULAKBİM)), Teşekkür kısmında “Kiremitci S” refere edilmiştir.

23. Kiremitci S, Kahraman K, Sertçelik A, Ortaç F. Small cell carcinoma in endometrium on the

base of extensive adenomyosis: differential diagnosis with immunochemistry. doi:

10.1007/s13691-011-0004-z, Int Canc Conf J, 1:27-32 (2012)

24. Kahraman K, Kiremitci S, Taşkın S, Kankaya D, Sertçelik A, Ortaç F. Expression pattern of

PAX2 in hyperplastic and malignant endometrium. Arch Gynecol Obstet, Jul;286(1):173-8

(2012)

25. Taşkın S, Gümüş Y, Kiremitci S, Kahraman K, Sertçelik A, Ortaç F. Malignant peritoneal

mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series

and review of the clinical and immunohistochemical features. Int J Clin Exp Pathol,

5(5):472-8 (2012)

26. Taşkin S, Dünder I, Erol E, Taşkin EA, Kiremitci S, Öztuna D, Sertçelik A. Roles of E-

cadherin and cyclooxygenase enzymes in predicting different survival patterns of optimally

cytoreduced serous ovarian cancer patients. Asian Pac J Cancer Prev, 13(11):5715-9 (2012)

27. Kiremitci S, Calayoglu R, Ensari A, Erbay B. Pathologist’s puzzle: Membranoproliferative

glomerulonephritis-like features in cryoglobulinemic glomerulonephritis. Pathol Res Pract,

Apr 15;208(4):254-8 (2012)

Curriculum Vitae – Saba Kiremitci M.D.

28. Kahraman K, Kurtay G, Kiremitci S. A presacral dermoid cyst with extremely high serum

CA19-9 level. J Obstet Gynaecol, Jan;32(1):103-104 (2012)

29. Göç G, Taşkın S, Kiremitci S, Kahraman K, Ortaç F. Endometrial kanser cerrahisini takiben

intraabdominal desmoid tümör gelişimi: Olgu sunumu. Türk Jinekolojik Onkoloji Dergisi

2012(4);15:1-2

30. Kankaya D, Kaygusuz G, Kiremitci S, Koçer U, Sak SD, “Malign Filloides Tümör

Zemininde Liposarkoma Gelişimi”, The Journal of Breast Health, 8(4): 206-209, (2012)

31. Erdemoğlu E, Günyeli İ, Güney M, Kiremitci S, Sertçelik A, Mungan T. Endometriyal

Polipden Gelişen Adenosarkom (Rabdomyosarkoma). Turkish Journal of Gynecologic

Oncology, (3):81-85 (2011)

32. Kiremitci S, Yüksel S, Tulunay O, Anafarta K. Scrotal Calcinosis: A Case Report and

Review of Literature, Ankara Üniversitesi Tıp Fakültesi Mecmuası, 64(1):46-51 (2011)

33. Ürün Y, Doğan İ, Kiremitci S, Akbulut H, İçli F. Angiosarcoma related to

immunosuppressive therapy 8 years after renal transplantation. Ann Transplant, 16(4): 138-

140 (2011)

34. Teke Z, Nessar G, Kiremitci S, Aksoy E, Erbil OH. Hepar lobatum Carcinomatosum

Associated with Metastatic Renal Carcinoma: An Unusual Cause of Liver Dysmorphy. Med

Princ Pract, 20:93-96 (2011)

35. Kaygusuz G, Kuzu I, Kiremitci S, Kankaya D, Biyikli Z. “Is CD117 Expression Related

with Plasma Cell Differentiation, IRF4/MUM1 and CD38 Expressions in Lymphoid

Neoplasms?”, Turk J Med Sci, 38(6), 511-517 (2008)

36. Onad İK, Kurt M, Akdoğan M, Kalkan İH, Kiremitci S, Ödemiş B, Oğuz D, Şaşmaz N. A

Rare Cause of Upper Gastrointestinal Bleeding: Stromal Tumor of Duodenum Masquerading

as Papilla Vateri. Am J Gastroenterol 2009;104:535

37. Kiremitci S, Tulunay O, Baltacı S, Gögüş O. Diagnostic Utility of Cytokeratins 7, 10 and 20

in Renal Cell Carcinoma and Oncocytoma. Turkish Journal of Pathology, 24(3): 140-146

(2008)

Curriculum Vitae – Saba Kiremitci M.D.

ORAL AND POSTER PRESENTATIONS IN INTERNATIONAL CONGRESS

1. M. T. Aydugan, D. Akbulut Ipek, C. Cansiz Ersöz, S. Kiremitci, B. Savas, A. Ensari,

Traditional serrated adenomas do not always prefer the colorectum. Virchows Archiv

(2018) 473 (Suppl 1): S14, OFP-04-012, 30th European Congress of Pathology, Bilbao,

Spain, 8-12 September 2018

(oral presentation, presenter: Saba Kiremitci)

2. D. Akbulut Ipek, F. G. Salman, S. Kiremitci, B. Savas, H. Cetinkaya, A. Ensari.

Involvement patterns in inflammatory bowel disease: differences between initial and

follow-up biopsies. Virchows Archiv (2018) 473 (Suppl 1): S14, OFP-04-014, 30th

European Congress of Pathology, Bilbao, Spain, 8-12 September 2018

(oral presentation)

3. A. Yavas, M. T. Aydugan, S. Kiremitci, B. Savas, H. Cetinkaya, A. Ensari. Various

histologic patterns of terminal ileitis and their diagnostic significance. Virchows Archiv

(2018) 473 (Suppl 1): S159, PS-20-001, 30th European Congress of Pathology, Bilbao,

Spain, 8-12 September 2018 (poster)

4. F. G. Salman, A. Yavas, S. Kiremitci, B. Savas, A. Ensari. Lymphocytic gastritis: what

is the underlying scenario? Virchows Archiv (2018) 473 (Suppl 1): S159, PS-20-002, 30th

European Congress of Pathology, Bilbao, Spain, 8-12 September 2018 (poster)

5. Sahin M, Keskin C, Kiremitci S, Erden E, Canpolat A, Cinel M, Canlar S, Demir O,

Gullu S, Emral R, Erdogan MF, Gedik V, Baskal N, Corapcioglu D. Is there a role of

immunohistochemical expression of pituitary hormones and proliferative marker ki-67 on

long-term outcome in our acromegalic patients? Endocrine Abstracts (2017) 49, 19th

European Congress of Endocrinology, Lisbon, Portugal, 20-23 May 2017.

DOI:10.1530/endoabs.49 (electronic poster, EP967)

6. Kiremitci S, Kendi Celebi Z, Ozturk B, Kankaya D, Duman N, Ates K, Erturk S,

Nergizoglu G, Kutlay S, Ensari A,Keven K. Pattern analysis in renal amyloidosis: Its role

in predicting patient outcome. XXXI International Congress of the International

Academy of Pathology and 28th Congress of the European Society of Pathology, 25 – 29

September 2016 (Poster)

7. Ocal E, Kiremitci S, Kirmizi A, Cansiz Ersoz C, Kursun N, Savas B, Ensari A. Changing

trends in H. Pylori gastritis: From antral predominant to corpus predominant? XXXI

International Congress of the International Academy of Pathology and 28th Congress of

the European Society of Pathology, 25 – 29 September 2016 (Poster)

8. Bal NB, Han S, Kiremitci S, Sadi G, Uludağ O, Demirel Yılmaz E. Effect of

endoplasmic reticulum stress inhibition on cardiac remodelling induced by hypertension,

The FEBS Journal volume 283, supplement1, September 2016, ISSN 1742-464X

(Poster, P035)

Curriculum Vitae – Saba Kiremitci M.D.

9. Bal NB, Han S, Kiremitci S, Sadi G, Uludağ O, Demirel Yılmaz E. Detrimental effect of

hypertension on myocardium was reversed by liver X receptor agonist GW3965. 41st

FEBS Congress on Molecular and Systems Biology for a Better Life, 2016. The FEBS

Journal, volume 283, supplement 1, September 2016. (Poster, P-06.01.2-002)

10. Kendi Çelebi Z, Kiremitci S, Öztürk B, Aktürk S, Erdoğmuş S, Duman N, Ateş K,

Ertürk S, Nergizoğlu G, Kutlay S, Sengül S, Ensari A, Kenan K. Secondary amyloidosis

with renal involvement and histopathologic correlation. Long term follow up results.

Nephrology Dialysis Transplantation 30 (Supplement 3): iii393–iii419, 2015,

doi:10.1093/ndt/gfv188.77 (Poster)

11. Kankaya D, Kiremitci S, Zengin K, Tuygun C, Sertcelik A. Telomerase expression in

urothelial carcinomasof the urinary bladder: Does it make sense for carcinogenesis or

prognosis?. Virchows Archiv, volume461, supplement1, September 2012, pg S289, PS-

22-036, 24th European Congress of Pathology, Prague, September 2012 (Poster)

12. Kiremitci S, Dizbay Sak S, Kankaya D, Percinel S. Immunohistochemical

characterization of salivary gland tumors. Virchows Archiv, volume461, supplement1,

September 2012, pg S149, PS-09-041, 24th European Congress of Pathology, Prague,

September 2012 (Poster)

13. Kankaya D, Kiremitci S, Ensari A, Sertcelik A. Incidental multifocal renal cell

carcinoma in graft nephrectomy with cellular rejection findings: Concurrence of papillary

renal cell carcinoma and renal carcinoma associated with Xp11.2 translocation. Virchows

Archiv, volume461, supplement1, September 2012, pg S289, PS-22-037, 24th European

Congress of Pathology, Prague, September 2012 (Poster)

14. Çakabay B, Kiremitci S, Bayar S, Aksel B, Tükün A, Akay G, Demirci S, Akgül H.

GASC1 gene expression in breast cancer. European Surgery, Vol. 44, Supplement Nr.

247, 2012 XVI. Annual Meeting of the European Society of Surgery—ESS 2012

Istanbul, November 22–24, 2012 (Poster, PP2)

15. Kiremitci S, Kahraman K, Sertçelik A, Ortaç F. Small cell carcinoma in endometrium on

the base of extensive adenomyosis: Differential diagnosis with immunochemistry. 17th

International Meeting of the European Society of Gynaecological Oncology, Milan, Italy,

September 11-14, A-373-0005-01347, 2011 (Poster, 160)

16. Taşkın S, Kiremitci S, Göç G, Kahraman K, Ortaç F. Early recurrence of cervical

villoglandular adenocarcinoma as peritoneal carcinomatosis. 17th International Meeting of

the European Society of Gynaecological Oncology, Milan, Italy, September 11-14, Poster

no: 153, 2011, International Journal of Gynecological Cancer 2011; 21, Supplement 3

(Poster)

17. Taşkın S, Ortaç F, Gümüş Y, Kiremitci S, Güngör M. Malignant primary peritoneal

mesothelioma: A diagnostic dilemma. 17th International Meeting of the European Society

of Gynaecological Oncology, Milan, Italy, September 11-14, 2011, International Journal

of Gynecological Cancer 2011; 21, Supplement 3 (Poster,282)

Curriculum Vitae – Saba Kiremitci M.D.

18. Unlu M, Kiremitci S, Ateş D, Ozluk Y, Ozdemir BH, Gonul II, Akaya B, Orhan D,

Gonlusen G, Baydar D, Sarioglu S. Crescent or full moon, pauci immune crescentic

nephritis. Virchows Arch (2011) 459 (suppl 1) S264, PS-21, 23rd European Congress of

Pathology, Aug 27- Sep 1, 2011 (Poster)

19. Kankaya D, Kiremitci S, Baltacı S, Bıyıklı Z, Tulunay O. The Role of MUC1, MUC2

and MUC7 in the Outcome of Superficial (Ta, T1) Urinary Bladder Cancer. Modern

Pathology, volume 24, supplement1, February 2011, poster no: 852. United States and

Canadian Academy of Pathology (USCAP), 100th Annual Meeting, February 26 – March

4, San Antonio, 2011 (Poster)

20. Kiremitci S, Kankaya D, Tulunay O, Baltaci S. Expression Pattern of Epidermal Growth

Factor Receptor (EGFR) in Clear Cell Renal Cell Carcinoma (CRCC): Association With

Clinicopathological Features and Clinical Outcome. Modern Pathology, volume 23,

supplement1, February 2010, poster no: 890. United States and Canadian Academy of

Pathology (USCAP), 99th Annual Meeting, March 20-26, Washington DC, USA, 2010

(Poster)

21. Kiremitci S, Kankaya D, Tulunay O, Baltaci S. Carbonic Anhydrase 9 (CA9) and

Caspase-9 (CASP-9) Expression in Clear Cell Renal Cell Carcinoma (CRCC):

Diagnostic, Prognostic and Therapeutic Implications. Modern Pathology, volume 23,

supplement1, February 2010, poster no: 891. United States and Canadian Academy of

Pathology (USCAP), 99th Annual Meeting, March 20-26, Washington DC, USA, 2010

(Poster)

22. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Expression of Caveolin-1 (CAV1),

PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence

For Prognostic Significance. Modern Pathology, volume 23, supplement1, February

2010, poster no: 884. United States and Canadian Academy of Pathology (USCAP), 99th

Annual Meeting, March 20-26, Washington DC, USA, 2010 (Poster)

23. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Impact of Epidermal Growth Factor

Receptor (EGFR), Gelsolin, Nf-Kb, and p53 Expression on Clinicopathological

Parameters in Clear Cell Renal Cell Carcinoma (CRCC). Modern Pathology, volume 23,

supplement1, February 2010, poster no: 885. United States and Canadian Academy of

Pathology (USCAP), 99th Annual Meeting March 20-26, Washington DC, USA, 2010

(Poster)

24. Kiremitci S, Tulunay O, Baltaci S, Gogus O. Prognostic utility of CyclinD3, CyclinE,

P27, MUC1 in renal cell carcinoma (RCC), Virchows Archiv, Vol 451(2), August 2007,

OP15-3, 21st European Congress of Pathology (ESP), September 8-13, İstanbul, 2007

(oral presentation, presenter:Saba Kiremitci)

25. Yilmaz G, Kiremitci S, Ensari A. FSGS variants: correlation of histopathological

features and clinical presentation. Virchows Archiv, Vol 451(2), August 2007, PP4-93,

21st European Congress of Pathology, September 8-13, İstanbul, 2007 (Poster)

26. Uygur A, Kaygusuz G, Kiremitci S, Ekinci C. Useful immunohistochemical markers in

differentiating hepatocellular carcinoma and metastatic adenocarcinoma. Virchows

Curriculum Vitae – Saba Kiremitci M.D.

Archiv, Vol 451(2), August 2007, PP2-247, 21st European Congress of Pathology,

September 8-13, İstanbul, 2007 (Poster)

27. Kiremitci S, Tulunay O, Baltaci S, Gogus O. Diagnostic and prognostic utility of

CyclinD1, CyclinD3, CyclinE, p27, MUC1, CD44, CK7 and CK20 in renal cell

carcinoma. Laboratory Investigation, Volume 87, supplement 1, March 2007, poster no:

67, (705), Tuesday afternoon, United States and Canadian Academy of Pathology

(USCAP), 96th Annual Meeting, California, USA, 2007 (Poster)

28. Kaygusuz G, Kuzu I, Kiremitci S, Karabork A. Immunohistochemical evaluation of

CD117 and IRF4/MUM1 expressions in lymphoid neoplasms. XIII. Meeting of the

European Association for Haematopathology, Syf 116, Vienna, Austria, October 7-12,

2006

(oral presentation)

ORAL AND POSTER PRESENTATIONS IN NATIONAL CONGRESS

1. Erdoğmuş Ş, Aktürk S, Kiremitci S, Ensari A, Kutlay S, Şengül Ş, Nergizoğlu G, Ertürk Ş,

Ateş K, Duman N, Keven K. Tip 2 diyabetik hastalarda non-diyabetik renal hastalık sıklığı,

klinik sonuçları ve belirleyicileri. Non-diabetic renal disease in type 2 diabetic patients:

prevalence, clinical predictors and outcomes. 33rd National Congress of Nephrology,

Hypertension, Dialysis and Transplantation (33. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve

Transplantasyon Kongresi), 2017

(oral presentation, SS/OP-010)

2. Erdoğmuş Ş, Kiremitci S, Kutlay S, Keven K, Ertürk Ş, Şengül Ş. Hematüri ile prezente olan

membranöz nefropati ve antiglomerüler bazal membran hastalığı tanılı olgu. 33rd National

Congress of Nephrology, Hypertension, Dialysis and Transplantation (33. Ulusal Nefroloji,

Hipertansiyon, Diyaliz ve Transplantasyon Kongresi), 2017 (poster PS/GN-055)

3. Kırmızı BA, Cansız Ersöz C, Kiremitci S, Kayı Cangır A,Sak S. Plevrada Müsin Pozitif

Epiteloid Mezotelyoma Olgu Sunumu. 26. Ulusal Patoloji ve 7. Ulusal Sitopatoloji Kongresi,

2016, (Poster)

4. Kendi Çelebi Z, Kiremitci S, Öztürk B, Aktürk S, Erdoğmuş S, Duman N, Ateş K, Ertürk S,

Nergizoğlu G, Kutlay S, Sengül S, Ensari A, Kenan Keven. Böbrekte sekonder amiloidozisin

histopatolojik bulguları ve klinik korelasyon. Turkish Nephrology, Dialysis and

Transplantation Journal Volume: 24, Number: 3, Supplement: 1, Year: 2015

(oral presentation, SS/OP-011)

5. Erdoğmuş Ş, Aktürk S, Çelebi ZK, Keven K, Şengül Ş, Duman N, Kiremitçi S, Kaygusuz G,

Altınbaş NK, Üstüner E. Bilateral renal kitle ve hematüri ile prezente olmuş diffüz büyük B

hücreli lenfoma olgusu. 17. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 27 Kasım

2014 (Poster PS-030)

Curriculum Vitae – Saba Kiremitci M.D.

6. Kendi Çelebi Z, Kiremitci S, Öztürk B, Aktürk S, Erdoğmuş S, Duman N, Ateş K, Ertürk S,

Nergizoğlu G, Kutlay S, Sengül S, Ensari A, Kenan Keven. Hızlı İlerleyen Renal AA

Amiloidozis: Klinik ve Histopatolojik Risk Faktörleri. 17. Ulusal Hipertansiyon ve Böbrek

Hastalıkları Kongresi, 27 Kasım 2014 (Poster PS-052)

7. Şen S, Kılıçaslan I, Başdemir G, Özdemir BH, Özağarı A, Şahin T, Akgün H, Gönül I,

Sarıoğlu S, Çakalağaoğlu F, Yıldız K, Kiremitci S. Türkiye’de nefropatoloji ve amiloidoz.

Turkish Nephrology, Dialysis and Transplantation Journal Volume: 23, Number: 3,

Supplement: 1, Year: 2014 (Poster)

8. Kankaya D, Kiremitci S, Zengin K, Tuygun C, Sertcelik A, Sertcelik N. Mesane ürotelyal

karsinomlarında telomeraz ekspresyonu: karsinogenezve prognozla ilişkisi. Türk Patoloji

Dergisi, cilt:28, ek sayı, Kasım 2012, sayfa 21, S38, 22. Ulusal Patoloji Kongresi, Antalya,

2012

(oral presentation)

9. Kankaya D, Kiremitci S, Sertcelik A, Gögüş Ç. Multifokal gelişen clear hücreli papiller

renal hücreli karsinoma: olgu sunumu. Türk Patoloji Dergisi, cilt:28, ek sayı, Kasım 2012,

sayfa 284, P625, 22. Ulusal Patoloji Kongresi, Antalya, 2012 (poster)

10. Kiremitci S, Dizbay Sak S, Kankaya D, Perçinel S. Tükrük bezi tümörlerinin

immünhistokimyasal karakterizasyonu. Türk Patoloji Dergisi, cilt:28, ek sayı, Kasım 2012,

sayfa 43, P47, 22. Ulusal Patoloji Kongresi, Antalya, 2012 (poster)

11. Kiremitci S, Ensari A. Lupus Nefriti Klasifikasyonu Bize Ne Veriyor? Turkish Journal of

Pathology, Nov 2011(27); 15, suppl, S33, 21. Ulusal Patoloji Kongresi, İzmir, 2011

(oral presentation, presenter: Saba Kiremitci)

12. Ünlü M, Kiremitci S, Ensari A, Özlük Y, Kılıçarslan I, Özdemir H, Ateş D, Baydar DE,

Gönül İI, Memiş L, Sarsık B, Şen S, Akkaya B, Orhan D, Gönlüşen G, Ellidokuz H, Ada S,

Çavdar C, Akagün T, Kamalı S, Aksu K, Yazısız V, Paydaş S, Soylu A, Sarıoğlu S. Hilal mi

Dolunay mı? Turkish Journal of Pathology, Nov 2011(27); 202, suppl, P497, 21. Ulusal

Patoloji Kongresi, İzmir, 2011 (poster)

13. Kankaya D, Kiremitci S, Yüksel S, Sertçelik A, Türkölmez K. Plazmasitoid Ürotelyal

Karsinoma: Olgu Sunumu. Turkish Journal of Pathology, Nov 2011(27); 260, suppl, P658,

21. Ulusal Patoloji Kongresi, İzmir, 2011(poster)

14. Çetintaş D, Karabörk A, Kiremitci S, Sertçelik A, Aral A, İnan B. Renal İskemi-

Reperfüzyon Hasarında İzlenen Histopatolojik Bulgular. Turkish Journal of Pathology, Nov

2011(27); 203, suppl, P501, 21. Ulusal Patoloji Kongresi, İzmir, 2011 (poster)

15. Kahraman K, Kiremitci S, Taşkın S, Kankaya D, Sertçelik A, Ortaç F. Hiperplastik ve

Malign Endometriyal Dokularda PAX2 Ekspresyonu. Turkish Journal of Pathology, Nov

2011(27); 10, suppl, S18, 21. Ulusal Patoloji Kongresi, İzmir, 2011

(oral presentation, presenter: Saba Kiremitci)

Curriculum Vitae – Saba Kiremitci M.D.

16. Şen S, Özlük Y, Kiremitci S, Akgün H, Sarsık B, Gümrükçü G, Özağarı A, Gönül İI, Taşlı

F, Ünlü M, Akkaya B, Canpolat T, Çolak A, Gönlüşen G, Çakaloğlu F, Mungan S, Çiriş M,

Tuncer İ, Sarıoğlu S, Memiş L, Ensari A, Kılıçarslan I. Renal Amiloidozis İnsidansı ve Renal

Patoloji Laboratuarlarının Deneyimi. Turkish Journal of Pathology, Nov 2011(27); 15, suppl,

S34, 21. Ulusal Patoloji Kongresi, İzmir, 2011

(oral presentation)

17. Göç G, Taşkın S, Kiremitçi S, Tolunay E, Ortaç F. Intraabdominal desmoid tumor following

endometrial cancer surgery. IX. Turkish-German Gynecology Congress, "Lecture and

Abstract Book, 319 pp., Antalya, 4-8 Mayıs 2011 (poster)

18. Kiremitci S, Kankaya D, Tulunay O, Baltaci S, Biyikli Z. Erken Evre (Ta, T1) Mesane

Ürotelyal Karsinomu Seyrinde MUC1 ve MUC2 Proteinlerinin Rolü. Turkish Journal of

Pathology, September 2010, volume 26, supplement, S-33. 20th National Pathology Congress

(20. Ulusal Patoloji Kongresi), 29 Eylül–3 Ekim 2010, Eskişehir

(oral presentation, presented by Saba Kiremitci)

19. Kiremitci S, Calayoğlu R, Karabulut YY, Erbay B, Ensari A. Kryoglobulinemik

Glomerülonefrit (CGN)’e Klinikopatolojik Yaklaşım: Olgu Sunumu. Turkish Journal of

Pathology, September 2010, volume 26, supplement,. 20. Ulusal Patoloji Kongresi,

Eskişehir, Ekim 2010 (poster: 362)

20. Kiremitci S, Karabörk A, Kankaya D, Kaygusuz G, Sertçelik A. Sistitis Glandülaris

Olgularına Klinikopatolojik Yaklaşım: İntestinal Tip Metaplazinin Önemi. Turkish Journal of

Pathology, September 2010, volume 26, supplement, 20.Ulusal Patoloji Kongresi, Eskişehir,

Ekim 2010 (poster: 536)

21. Karabörk A, Kiremitci S, Sertçelik A, Akgül H. Over Lokalizasyonlu Karsinosarkom

Olgusu. Turkish Journal of Pathology, September 2010, volume 26, supplement, 20.Ulusal

Patoloji Kongresi, Eskişehir, Ekim 2010 (poster: 261)

22. Kankaya D, Kaygusuz G, Kiremitci S, Koçer U, Sak SD. Malign Filloides Tümör

Zemininde Liposarkoma Gelişimi (Olgu Sunumu). Turkish Journal of Pathology, September

2010, volume 26, supplement. 20. Ulusal Patoloji Kongresi, Eskişehir, Ekim 2010 (poster:

341)

23. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. EGFR Expression Sites in “Clear” Renal Cell

Carcinomas. Relation with Prognosis (“Clear” Renal Hücreli Karsinomalarda EGFR

Ekspresyon Bölgeleri ve Prognoz İlişkisi). Turkish Journal of Pathology, October 2009,

volume 25, supplement, S-18. 19th National Pathology Congress, Oct 7-11, 2009, Kibris

(oral presentation)

24. Kiremitci S, Tulunay O, Baltaci S, Percinel S. The Role of CyclinD1, CyclinD3, CyclinE,

p27, CD44, MUC1, CK7 and CK20 Proteins in Differential Diagnosis of Renal Cell

Carcinoma. Their Relation with Prognosis. An Immunohistochemical Study. 18th National

Pathology Symphosium Oncologic Pathology, May 7-11, 2006, Izmir, Turkey

Curriculum Vitae – Saba Kiremitci M.D.

(oral presentation, presented by Saba Kiremitci)

25. Kaygusuz G, Kuzu I, Kankaya D, Kiremitci S, Uygur A. CD117 Protein Expression in

Hodgkin and NonHodgkin Lymphoma. Relation with Plasma Cell Differentiation. Turkish

Journal of Hematology, supplement 1, vol.23, no:3, presentation:50. XXXII. National

Hemathology Congress, Nov 8-12, 2006, Antalya, Turkey

(oral presentation)

26. Kiremitci S, Tulunay Ö, Baltacı S, Perçinel S. Renal hücreli karsinoma tiplendirmesi ve

prognozunda CyclinD1, CyclinD3, CyclinE, p27, CD44, MUC1, CK7 ve CK20’nin yeri ve

ilişkileri; immünhistokimyasal çalışma. Poster no: 426, 18. Ulusal Patoloji Sempozyumu

Onkolojik Patoloji, İzmir, Mayıs 2006

(oral presentation, presenter: Saba Kiremitci)

27. Heper AO, Kiremitci S, Kankaya D, Erden E, Erdoğan A. İntrakraniyal embriyonal

rabdomyosarkom: bir olgu eşliğinde rabdoid morfolojili intrakraniyal tümörlerin ayırıcı tanısı

ve klinik bilginin önemi. 18. Ulusal Patoloji Sempozyumu, Onkolojik Patoloji, Çeşme, Mayıs

2006 (poster: 028)

28. Tanır P, Uygur A, Savaş B, Yılmaz G, Kiremitci S, Ensari A. Gastrik heterotopik pankreas

zemininde adenokarsinom gelişimi; olgu sunumu. 18. Ulusal Patoloji Sempozyumu, Çeşme,

Mayıs 2006 (poster: 228)

29. Kiremitci S, Perçinel S, Ensari A, Erekul S, Sarı ME. Vulvada anjiyomyofibroblastoma

olgusu. 17. Ulusal Patoloji Sempozyumu, Gaziantep, Ekim 2004 (poster)

30. Kiremitci S, Perçinel S, Kaygusuz G, Sak SD, Erden E, Demirer S. Dev “solid cell nest”

içeren tiroiditis olgusu. 17. Ulusal Patoloji Sempozyumu, Gaziantep, Ekim 2004 (poster)

31. Kiremitci S, Erinanç H, Perçinel S, Sak SD, Sertçelik A, Erekul S, Ökten İ. Akciğer

metastaz odağında rabdomyoblastik hücreler içeren osteosarkoma olgusu. 17. Ulusal Patoloji

Sempozyumu, Gaziantep, Ekim 2004 (poster)

32. SanatiPour M, Heper AO, Hacıahmetoğlu (Kiremitci) S, Erden E, Deda G. Santral sinir

sisteminde histiositlerin neden olabildikleri tanı güçlükleri. 16. Ulusal Patoloji Kongresi,

Konya, Mayıs 2003 (poster)